Background: Studies in children and adolescents have associated early developmental manganese (Mn) exposure with inattention, impulsivity, hyperactivity, and fine motor deficits, and our rodent studies of early life Mn exposure have recapitulated many of these outcomes, demonstrating causality. There are currently no recognized therapies/interventions other than exposure prevention to mitigate the neurotoxic effects of developmental Mn exposure. One possible preventive treatment is to supplement the maternal diet with additional choline during pregnancy. Maternal choline supplementation (MCS) has been shown to improve offspring cognitive function in humans and animal models, and lessens dysfunction caused by various developmental insults. Objectives: Determine whether MCS during pregnancy and lactation protects against Mn-induced impairments in attention, impulse control, learning, behavioral reactivity, and sensorimotor function. Methods: Starting at gestational day 3 (G3), pregnant dams were given standard diet or diet with additional choline (4x the level in standard diets) throughout gestation and lactation until offspring were weaned on PND 21. Pups were exposed orally to 0 or 50 mg Mn/kg/day during early postnatal life (PND 1-21). In adulthood, animals were tested in the five-choice serial reaction time task and the Montoya staircase task, to assess impulsivity, focused and selective attention, behavioral reactivity to errors or omission of an expected reward, and sensorimotor function. Results: MCS intervention was partially effective in protecting against the Mn-induced deficits, with the degree of benefit varying with the specific domain of function. Specifically, MCS lessens differences between Mn and control animals in attentional function and reactivity to committing an error or not receiving an expected reward. MCS does not protect against Mn-induced sensorimotor dysfunction. Finally, in the absence of Mn exposure, MCS produces lasting benefits in attentional function and reactivity to errors. Conclusions: MCS was partially effective in alleviating Mn-induced deficits: MCS normalized Mn exposed animals in the domains of attentional function and behavioral reactivity. These findings have implications for understanding the molecular mechanisms by which both MCS and Mn produce lasting cognitive changes, and provide further evidence that MCS benefits offspring. These findings, taken with evidence from other studies demonstrating the benefit of MCS to offspring and the fact that ~90% of women consume less than the adequate intake (AI) of choline, inform the recommendation that MCS should be considered for pregnant women.